<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82606">
  <stage>Registered</stage>
  <submitdate>14/02/2008</submitdate>
  <approvaldate>15/02/2008</approvaldate>
  <actrnumber>ACTRN12608000092392</actrnumber>
  <trial_identification>
    <studytitle>chronOS Implant Evaluation Study. The Canberra Surgicentre and Synthes Australia are conducting a clinical study to evaluate the performance of chronOS granules (bone substitute) following the extraction of wisdom tooth/teeth to prevent the risk of periodontal defects.</studytitle>
    <scientifictitle>To measure the efficacy of beta-TriCalcium Phosphate (TCP) bone graft filler in preventing periodontal defect on the distal aspect of the M2 following M3 extraction.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Not applicable</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Mandibular M3 extraction may result in bony periodontal defects on the distal surface of the adjacent second molar.</healthcondition>
    <healthcondition>Dental health.</healthcondition>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Inflammatory bowel disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>beta-TriCalcium Phosphate granules will be placed in the socket of one of the bilaterally extracted M3. After six months a first set of x-rays will be done to observe bone level at the cemento-enamel junction of the chronOS filled socket versus the non-filled socket. A second set of x-rays will be done at 12 months.</interventions>
    <comparator>No treatment</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To prospectively determine using a non-randomized single blind controlled series whether subjects may benefit from periodontal healing after using a synthetic  B-TCP bone graft material at the time of M3 extraction.</outcome>
      <timepoint>6 and 12 month follow up after operation.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Prevention of peridontal defects.</outcome>
      <timepoint>18 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Not applicable</outcome>
      <timepoint>Not applicable</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Age &gt;= 18 years
Removal of two mandibular M3
Mesioangular or horizontal M3 position
Agreement for return follow-up for at least 12 months.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Age &lt; 18 years
No adjacent M2
Diabetic
Chronic steroid use.
Malignant condition
Previous radiotherapy to the maxilla or mandible.
Significant difference between the  cementoenamel junction (CEJ) bilaterally, defined as attachment level variance of 1mm or more.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/07/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>2612</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Canberra Surgicentre</primarysponsorname>
    <primarysponsoraddress>11 Torrens Street
Braddon ACT 2612</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Canberra Surgicentre</fundingname>
      <fundingaddress>11 Torrens Street
Braddon ACT 2612</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Commercial sector/Industry</sponsortype>
      <sponsorname>Synthes</sponsorname>
      <sponsoraddress>1 Lucknow Road
Riverside Corporate Park
North Ryde NSW 2113</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of this study is to confirm that chronOS (bone substitute) can decrease the risk of peridodontal defects following extraction of their wisdom tooth/teeth (M3) extraction.
It has been reported that by extracting the mandibular M3 bony peridontal defects can occur on the distal surface of the adjacent second molar. These bony defects are particularly present in patients who had their wisdom teeth extracted when over 26 years of age.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Canberra  Surgicentre Ethics committee</ethicname>
      <ethicaddress>11 Torrens Street
Braddon ACT 2612</ethicaddress>
      <ethicapprovaldate>4/06/2007</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Alisa Stevenson</name>
      <address>11 Torrens Street
Braddon ACT 2612</address>
      <phone>(02) 6276 3920</phone>
      <fax />
      <email>clinicalmanager@surgicentre.com.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Hailey Cordina</name>
      <address>11 Torrens Street
Braddon ACT 2612</address>
      <phone>(02) 6276 3920</phone>
      <fax />
      <email>h.cordina@surgicentre.com.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Alisa Stevenson</name>
      <address>11 Torrens Street
Braddon ACT 2612</address>
      <phone>(02) 6276 3920</phone>
      <fax />
      <email>clinicalmanager@surgicentre.com.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>